<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">856495</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2022.856495</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Rational Design of a Gd(III)&#x2013;Cu(II) Nanobooster for Chemodynamic Therapy Against Cancer Cells</article-title>
<alt-title alt-title-type="left-running-head">Shi et al.</alt-title>
<alt-title alt-title-type="right-running-head">Gd(III)&#x2013;Cu(II) Nanobooster for Chemodynamic Therapy</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Xin-Ya</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Ting-Xiao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ao-Lin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Li-Tao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Wen-Chang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhong</surname>
<given-names>Hai-Jiang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Shun-Lin</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gu</surname>
<given-names>Yu-Lan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shen</surname>
<given-names>Lei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1639051/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Oncology</institution>, <institution>Changshu No.2 People&#x2019;s Hospital</institution>, <addr-line>Changshu</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Jiangsu Laboratory of Advanced Functional Materials</institution>, <institution>College of Material Engineering</institution>, <institution>Changshu Institute of Technology</institution>, <addr-line>Changshu</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>State Key Laboratory of Materials-Oriented Chemical Engineering</institution>, <institution>College of Chemical Engineering</institution>, <institution>Nanjing Tech University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/718024/overview">Clara S. B. Gomes</ext-link>, New University of Lisbon, Portugal</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1196550/overview">Karla Juarez-Moreno</ext-link>, National Autonomous University of Mexico, Mexico</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/744366/overview">Fu-Gen Wu</ext-link>, Southeast University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Shun-Lin Zhang, <email>zhangsl93@njtech.edu.cn</email>; Yu-Lan Gu, <email>guyulan@263.net</email>; Lei Shen, <email>leishen@cslg.edu.cn</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Inorganic Chemistry, a section of the journal Frontiers in Chemistry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>856495</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>02</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Shi, Shen, Zhang, Tan, Shen, Zhong, Zhang, Gu and Shen.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Shi, Shen, Zhang, Tan, Shen, Zhong, Zhang, Gu and Shen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Copper (II) containing coordination complexes have attracted much attention for chemodynamic therapy (CDT) against cancer cells. In this study, the bimetallic nanobooster [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O was prepared by a solvothermal method based on tetrazole carboxylic acid ligand H<sub>4</sub>L [H<sub>4</sub>L &#x3d; 3,3-di (1H-tetrazol-5-yl) pentanedioic acid]. It showed considerable cytotoxicity toward three kinds of human cancer cells (HeLa, HepG2, and HT29). The MTT assay showed that the IC<sub>50</sub> (half-maximal inhibitory concentration) of the complex NPs on HeLa cells (4.9&#xa0;&#x3bc;g/ml) is superior to that of HepG2 (11.1&#xa0;&#x3bc;g/ml) and HT29 (5.5&#xa0;&#x3bc;g/ml). This result showed that [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O NPs can inhibit cell proliferation <italic>in vitro</italic> and may be potential candidates for chemodynamic therapy. In addition, the cytotoxicity was also confirmed by the trypan blue staining experiment. The results promise the great potential of Gd(III)&#x2013;Cu(II) for CDT against cancer cells.</p>
</abstract>
<kwd-group>
<kwd>tetrazole</kwd>
<kwd>Gd(III)&#x2013;Cu(II)</kwd>
<kwd>crystal structure</kwd>
<kwd>chemodynamic therapy</kwd>
<kwd>nanobooster</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Currently, phototherapies, including photodynamic therapy (PDT), photothermal therapy (PTT), and chemodynamic therapy (CDT) have received tremendous attention as advanced methods for cancer treatment. Both the treatments can induce cancer cell apoptosis by producing reactive oxygen species (ROS) (<xref ref-type="bibr" rid="B23">Palao et al., 2016</xref>; <xref ref-type="bibr" rid="B17">Lin et al., 2018</xref>; <xref ref-type="bibr" rid="B7">Guo et al., 2020</xref>; <xref ref-type="bibr" rid="B9">Jia et al., 2022</xref>). Among these, phototherapy is restricted to further application in clinical treatment due to the limitation of tissue light penetration and hypoxic environment. CDT does not rely on light and only uses copper or iron to catalyze endogenous H<sub>2</sub>O<sub>2</sub> <italic>via</italic> a Fenton-like reaction to produce hydroxyl radicals (&#x2022;OH) to kill cancer cells. For example, Cao et al. designed a Mn&#x2013;Cu bimetallic complex for CDT; this complex can efficiently generate ROS and reduce the glutathione (GSH) level so as to improve the CDT effect (<xref ref-type="bibr" rid="B3">Cao et al., 2019</xref>).</p>
<p>Coordination complexes have been designed and developed as multifunctional materials for cancer treatment (<xref ref-type="bibr" rid="B39">Yang et al., 2014</xref>; <xref ref-type="bibr" rid="B100">Yu et al., 2021</xref>). The tetrazole carboxylic acid ligand has two functional groups: tetrazole ring and carboxyl group, which enable it to have excellent coordination ability and more coordination modes with metal ions. 1) Ligands containing nitrogen and oxygen atoms provide the possibility of regulating the final supramolecular structure due to the diversity of coordination modes with metals. 2) The diverse coordination modes of tetrazole and carboxylate groups can form various different coordination connection modes. 3) Abundant N and O atoms can participate in the formation of hydrogen bonds, which can stabilize the supramolecular assembly. Multiple modes of monodentate coordination, chelate coordination, and bridged coordination can be realized. Therefore, the research on tetrazole carboxylic acid complexes is of great significance (<xref ref-type="bibr" rid="B1">Arom&#xed; et al., 2011</xref>; <xref ref-type="bibr" rid="B15">Fan et al., 2021</xref>; <xref ref-type="bibr" rid="B22">Liu et al., 2012</xref>; <xref ref-type="bibr" rid="B28">Sun et al., 2012</xref>; <xref ref-type="bibr" rid="B8">Huang et al., 2013</xref>; <xref ref-type="bibr" rid="B14">Li et al., 2013</xref>; <xref ref-type="bibr" rid="B4">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="B21">Liu et al., 2015</xref>; <xref ref-type="bibr" rid="B20">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B32">Wu et al., 2011</xref>). At present, the synthesis and structure of a variety of tetrazole carboxylic acids and their coordination complexes and properties have been studied, showing their important application value in the fields of molecular magnetism, molecular absorption, and catalysis (<xref ref-type="bibr" rid="B30">Wriedt et al., 2012</xref>; <xref ref-type="bibr" rid="B49">Zou et al., 2014</xref>; <xref ref-type="bibr" rid="B33">Wu et al., 2015</xref>; <xref ref-type="bibr" rid="B35">Yang et al., 2015</xref>; <xref ref-type="bibr" rid="B48">Zou et al., 2015</xref>). With the in-depth study of tetrazole carboxylic acid complexes, it is found that they have special biological activities against human tumor cells (<xref ref-type="bibr" rid="B31">Wriedt et al., 2013</xref>; <xref ref-type="bibr" rid="B13">Li et al., 2015</xref>; <xref ref-type="bibr" rid="B27">Sun et al., 2016</xref>; <xref ref-type="bibr" rid="B46">Zhu et al., 2016</xref>).</p>
<p>In previous studies, we have reported a series of tetrazole carboxylate&#x2013;based complexes as nanoboosters, which can boost O<sub>2</sub> or H<sub>2</sub>O<sub>2</sub> to generate ROS to induce cancer cell apoptosis, exhibiting high toxicity and excellent biocompatibility for photodynamic therapy (<xref ref-type="bibr" rid="B36">Yang G et al., 2018</xref>; <xref ref-type="bibr" rid="B43">Zhai et al., 2018</xref>; <xref ref-type="bibr" rid="B41">Yang et al., 2019</xref>; <xref ref-type="bibr" rid="B47">Zhu et al., 2019</xref>; <xref ref-type="bibr" rid="B34">Xu et al., 2020</xref>; <xref ref-type="bibr" rid="B38">Yang et al., 2020</xref>). As an extension of our research, the tetrazole carboxylic acid ligand&#x2013;based H<sub>4</sub>L (<xref ref-type="fig" rid="F7">Scheme 1</xref>) was selected for self-assembly with Gd(III)&#x2013;Cu(II) ions, and a new heteronuclear complex [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O was obtained with good antitumor properties (<xref ref-type="fig" rid="F7">Scheme 1</xref>). The complex structure was characterized by X-ray single crystal diffraction, and its structure and properties were analyzed to find its potential application. The NPs of the complex were prepared by a nanocoprecipitation method with PEG-<sub>2000</sub> (polyethylene glycol) to behave as a booster that is capable of boosting H<sub>2</sub>O<sub>2</sub> to produce &#x2022;OH to induce apoptosis. Human cervical cancer cells (HeLa), human hepatoma cells (HepG2), and human colorectal adenocarcinoma cells (HT29) were selected to investigate the chemodynamic therapy efficacy <italic>in vitro</italic>. In addition, the half-maximal inhibitory concentration (IC<sub>50</sub>) of 4.9&#xa0;&#x3bc;g/ml, 11.1&#xa0;&#x3bc;g/ml, and 5.5&#xa0;&#x3bc;g/ml with irradiation was observed in the MTT assay. The results showed that [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O NPs can inhibit cell proliferation in three kinds of tumor cells, and have the lowest IC<sub>50</sub> value for HeLa cells, which may be potential candidates for chemodynamic therapy.</p>
<fig id="F7" position="float">
<label>SCHEME 1</label>
<caption>
<p>Drawing for H<sub>4</sub>L ligand.</p>
</caption>
<graphic xlink:href="fchem-10-856495-g007.tif"/>
</fig>
</sec>
<sec id="s2">
<title>2 Experimental Section</title>
<sec id="s2-1">
<title>2.1 Materials and Methods</title>
<p>The H<sub>4</sub>L ligand was prepared according to the literature methods (<xref ref-type="bibr" rid="B16">Lin et al., 2008</xref>). All commercially available chemicals of analytical grade were used directly. The FT-IR spectra as the KBr disk were recorded on a Nicolet-IS10 spectrometer. The elemental analysis of CHNO was conducted by using a EA1110 CHNO-S micro analyzer. Luminescence properties were analyzed by using a Hitachi F-7000 fluorescence spectrophotometer. Powder X-ray diffraction (PXRD) measurements were carried out by using a Rigaku D/MAX 2200 diffractometer. Scanning electron microscopy (SEM) was performed using a Hitachi S-4800. UV&#x2013;Vis spectroscopy was conducted using a Shimadzu UV-3600 spectrophotometer. Single crystal X-ray diffraction was carried out using a Bruker SMART APEX II DUO diffractometer. The cellular images were recorded by using a Bruker <italic>In Vivo</italic> Imaging System Fx Pro.</p>
</sec>
<sec id="s2-2">
<title>2.2 Synthesis of [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O</title>
<p>0.1&#xa0;mmol (0.0268&#xa0;g) H<sub>4</sub>L was dissolved in 6&#xa0;ml distilled water. The solution was adjusted to pH &#x3d; 6 using 2% KOH. Then, 0.4&#xa0;mmol (0.0451&#xa0;g) Gd(NO<sub>3</sub>)<sub>3</sub>&#xb7;6H<sub>2</sub>O, 0.1&#xa0;mmol (0.0242&#xa0;g) Cu(NO<sub>3</sub>)<sub>2</sub>&#xb7;3H<sub>2</sub>O, and 1&#xa0;ml of EtOH were added to it. Then, the solution was heated for 48&#xa0;h at 130 &#xb0;C in a stainless steel reactor lined with Teflon. After cooling to room temperature, blue block-shape crystals of [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O were obtained by filtration and washed with EtOH. Yield: 59% based on Cu<sup>2&#x2b;</sup>. Anal. calculated for C<sub>14</sub>H<sub>40</sub>CuGd<sub>2</sub>N<sub>16</sub>O<sub>24</sub>: C 14.08; H 3.38; N 18.76% found: C 14.32; H 3.36; N 18.48%. IR (KBr, cm<sup>&#x2212;1</sup>) 3412.95 (s), 2367.31 (w), 1566.55 (m), 1411.36 (m), 1295.05 (s), 1237.85 (w), 1142.94 (w), 1027.44 (w), 922.03 (w), 660.89 (w), 624.05 (w).</p>
</sec>
<sec id="s2-3">
<title>2.3 X-Ray Crystallography</title>
<p>The structure of the complex synthesized in the experiment was studied by using X-ray single-crystal diffraction. Crystallographic data for the complex were recorded on a Bruker Apex II DUO diffractometer with a Mo&#x2013;<italic>K</italic>&#x3b1; source (<italic>&#x3bb;</italic> &#x3d; 0.71073&#xa0;&#xc5;) at room temperature. The relevant data were collected and full matrix least squares correction was performed with the direct method (SHELXTL-2014) to analyze the crystal structure (<xref ref-type="bibr" rid="B25">Sheldrick, 2008</xref>). <xref ref-type="table" rid="T1">Table 1</xref> shows the crystallization parameter data of the target complex, and main bond lengths and angles and relevant hydrogen bond parameter data are shown in Table S1 and Table S2 (ESI&#x2020;).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Crystallographic parameters of [Gd<sub>2</sub>Cu(L)<sub>2</sub>H<sub>2</sub>O<sub>10</sub>]&#xb7;6H<sub>2</sub>O.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Empirical formula</th>
<th align="center">C<sub>14</sub>H<sub>28</sub>CuGd<sub>2</sub>N<sub>16</sub>O<sub>18</sub>&#xb7;6H<sub>2</sub>O</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Formula mass</td>
<td align="center">1194.66</td>
</tr>
<tr>
<td align="left">Crystal system</td>
<td align="center">Monoclinic</td>
</tr>
<tr>
<td align="left">Space group</td>
<td align="center">P21/n</td>
</tr>
<tr>
<td align="left">
<italic>a</italic> (&#xc5;)</td>
<td align="center">10.4322 (4)</td>
</tr>
<tr>
<td align="left">
<italic>b</italic> (&#xc5;)</td>
<td align="center">9.8578 (4)</td>
</tr>
<tr>
<td align="left">
<italic>c</italic> (&#xc5;)</td>
<td align="center">19.1734 (7)</td>
</tr>
<tr>
<td align="left">
<italic>&#x3b1;</italic> (&#xb0;)</td>
<td align="center">90.00</td>
</tr>
<tr>
<td align="left">
<italic>&#x3b2;</italic> (&#xb0;)</td>
<td align="center">104.0440 (4)</td>
</tr>
<tr>
<td align="left">
<italic>&#x3b3;</italic> (&#xb0;)</td>
<td align="center">90.00</td>
</tr>
<tr>
<td align="left">
<italic>V</italic> (&#xc5;<sup>3</sup>)</td>
<td align="center">1912.83 (13)</td>
</tr>
<tr>
<td align="left">
<italic>Z</italic>
</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">
<italic>T</italic>/K</td>
<td align="center">296</td>
</tr>
<tr>
<td align="left">D<sub>calcd (</sub>g.cm<sup>&#x2212;3</sup>)</td>
<td align="center">2.074</td>
</tr>
<tr>
<td align="left">
<italic>&#x03BC;</italic> (mm<sup>&#x2212;1</sup>)</td>
<td align="center">4.084</td>
</tr>
<tr>
<td align="left">Reflections collected</td>
<td align="center">19693</td>
</tr>
<tr>
<td align="left">Unique reflections (R<sub>int</sub>)</td>
<td align="center">3878 (0.0192)</td>
</tr>
<tr>
<td align="left">No. of observations (I &#x3e; 2.00)</td>
<td align="center">3680</td>
</tr>
<tr>
<td align="left">No. of variables</td>
<td align="center">259</td>
</tr>
<tr>
<td align="left">R<sub>1</sub>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref> wR<sub>2</sub>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref> (I &#x3e; 2sigma(I))</td>
<td align="center">0.0177, 0.0450</td>
</tr>
<tr>
<td align="left">R<sub>1</sub>, wR<sub>2</sub> (all data)</td>
<td align="center">0.0189, 0.0458</td>
</tr>
<tr>
<td align="left">GOF<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td align="center">0.990</td>
</tr>
<tr>
<td align="left">&#x394;/&#x3c1;<sub>max</sub> (e/&#xc5;<sup>3</sup>)</td>
<td align="center">0.537</td>
</tr>
<tr>
<td align="left">&#x394;/&#x3c1;<sub>min</sub> (e/&#xc5;<sup>3</sup>)</td>
<td align="center">&#x2212;0.631</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>R &#x3d; &#x3a3;&#x7c;&#x7c;F<sub>o</sub>&#x7c;-&#x7c;F<sub>c</sub>&#x7c;/&#x3a3; &#x7c;F<sub>o</sub>&#x7c;.</p>
</fn>
<fn id="Tfn2">
<label>b</label>
<p>Rw &#x3d; {&#x3a3; w (F<sub>o</sub>
<sup>2</sup>-F<sub>c</sub>
<sup>2</sup>)<sup>2</sup>/&#x3a3; w (F<sub>o</sub>
<sup>2</sup>)<sup>2</sup>}<sup>1/2</sup>.</p>
</fn>
<fn id="Tfn3">
<label>c</label>
<p>GOF &#x3d; {w (F<sub>o</sub>
<sup>2</sup>-F<sub>c</sub>
<sup>2</sup>)<sup>2</sup>)/(n-p)}<sup>1/2</sup>, where n &#x3d; number of reflections and p &#x3d; total numbers of parameters refined.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2-4">
<title>2.4 Preparation of the Complex Nanoparticles</title>
<p>Due to the poor solubility of the complex, the NPs with good dispersibility in water were prepared by nanocoprecipitation with PEG<sub>-2000</sub> by a &#x201c;bottom&#x2013;up&#x201d; method, and this can be universally found in the literature (<xref ref-type="bibr" rid="B12">Li et al., 2017</xref>; <xref ref-type="bibr" rid="B37">Yang J et al., 2018</xref>). For a typical experiment, tetrahydrofuran (THF, 1&#xa0;ml) solution containing the complex (2&#xa0;mg) and PEG<sub>-2000</sub> (5&#xa0;mg) was sonicated into distilled water. After stirring for 10&#xa0;min, N<sub>2</sub> was bubbled for 20&#xa0;min to remove THF. The solution was then stored in the dark for further use (<xref ref-type="bibr" rid="B37">Yang J et al., 2018</xref>). Finally, NPs of the complex in the solution were obtained by centrifugation. The as-prepared NPs have good dispersibility in water. In addition, nanoparticles have enhanced permeability and retention (EPR) effect and can passively target the tumor to enhance uptake.</p>
</sec>
<sec id="s2-5">
<title>2.5 Cell Culture and MTT Assay</title>
<p>HeLa, HepG2, and HT29 cell lines were obtained from the Cell Bank of SIBCB, CAS (China). These cells were cultured in the minimum essential medium (DMEM, Gibco; Thermo Fisher Scientific) with 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific). All the culture media contain 100 units/mL penicillin and 100&#xa0;&#x3bc;g/ml streptomycin. The cells were cultured at 37&#xb0;C in a humidified incubator with 5% CO<sub>2</sub>.</p>
<p>HeLa, HepG2, and HT29 cell lines were seeded in 96-well plates at a density of 1 &#xd7; 10<sup>5</sup> cells/ml, 5 &#xd7; 10<sup>4</sup> cells/ml, and 5 &#xd7; 10<sup>4</sup> cells/ml, respectively, for 12&#xa0;h to get attached. Cell viability assays of the NPs were conducted by first dissolving in distilled water, which were diluted with DMEM to various concentrations and transferred in the 96-well plate with the same volume (200&#xa0;&#xb5;L) in each well for 24&#xa0;h. Then, the plate was irradiated with a xenon lamp (30&#xa0;mW/cm<sup>2</sup>) for 5&#xa0;min. Cell viability was determined by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. MTT in PBS (5&#xa0;mg/ml, 20&#xa0;&#x3bc;L) was added to each well and incubated for 3&#xa0;h under the same conditions at 37&#xb0;C. Then, the medium was removed and 200&#xa0;ml DMSO was added. The plate was agitated on a Bio-Tek microplate reader at ambient temperature. The average absorbance of the no cell line was subtracted from the readings of the other wells. The cell viability was calculated by the following equation: cell viability (%) &#x3d; mean absorbance in each group incubated with different concentrations of NPs/mean absorbance in the control group. The average absorbance of the blank well (no cells) was removed from the data of the other wells.</p>
</sec>
<sec id="s2-6">
<title>2.6 Measurement of &#x2022;OH Generation</title>
<p>To investigate the &#x2022;OH generation, the solution of the complex NPs (0.5&#xa0;ml, 10&#xa0;&#x3bc;g/ml) was added into methylene blue (MB, a dye that can be faded by &#x2022;OH) solution (0.5&#xa0;ml, 20&#xa0;&#x3bc;g/ml) to obtain a mixed solution and allowed to stand at room temperature for 30&#xa0;min. The absorbance value of the MB and mixed solution of MB with NPs was recorded at about 665&#xa0;nm <italic>via</italic> UV&#x2013;Vis spectroscopy.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and Discussions</title>
<sec id="s3-1">
<title>3.1 Synthesis and Characterization of Complex NPs</title>
<p>In weak acidic conditions, hydrothermal reactions of H<sub>4</sub>L and metal salt with a ratio of 1:5 in MeOH-H<sub>2</sub>O at 130&#xb0;C for 2&#xa0;days provided the complex in moderate of 59%. Crystals of the complex are all air-stable. The elemental analysis reveals that the component is in well-agreement with the results of the X-ray diffraction analysis.</p>
<p>The main IR peaks of the complex are as follows: the absorption peak at 3412.9&#xa0;cm<sup>&#x2212;1</sup> is attributed to water molecules, the peak at 2367.3&#xa0;cm<sup>&#x2212;1</sup> belongs to the carboxyl peak, and peaks within 1566.5&#xa0;cm<sup>&#x2212;1</sup> to 1411.3&#xa0;cm<sup>&#x2212;1</sup> are attributed to the tetrazole ring conjugate system of the ligand. The results of the infrared analysis are in well-accordance with the composition of the complex.</p>
<p>X-ray diffraction (XRD) was used to characterize the stability of the complex NPs in water. As shown in <xref ref-type="fig" rid="F1">Figure 1A</xref>, the patterns are exactly identical to those simulated from single-crystal analysis, indicating the high phase purity of the bulk crystal. Notably, the PEG-free complex NPs were prepared by the same method, maintaining the structural integrity of the framework after exposure to water at 25&#xb0;C for 1&#xa0;day and demonstrating excellent stability of these complex NPs.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>(A)</bold> XRD patterns of the complex; <bold>(B)</bold> schematic diagram of the fluorescence emission spectrum of the ligand and complex NPs; <bold>(C)</bold> MB degradation in the presence of H<sub>2</sub>O<sub>2</sub> with the complex NPs for the detection of generation of hydroxyl; <bold>(D)</bold> DLS and SEM images of the complex NPs.</p>
</caption>
<graphic xlink:href="fchem-10-856495-g001.tif"/>
</fig>
<p>The fluorescence properties of the ligand H<sub>4</sub>L and complex NPs were studied by using a fluorescence spectrophotometer at room temperature. As shown in <xref ref-type="fig" rid="F1">Figure 1B</xref>, through the exploration of its emission peak, the ligand H<sub>4</sub>L has the largest characteristic emission peak at 426&#xa0;nm with 374&#xa0;nm excitation. With 311&#xa0;nm excitation, the complex has a maximum emission peak at 469&#xa0;nm. The observed red shift of 43&#xa0;nm for the complex is in good agreement with the previously reported complex (<xref ref-type="bibr" rid="B6">Guo et al., 2018</xref>). The shifts are probably due to &#x3c0;&#x2a;&#x2013;&#x3c0; transitions of the corresponding ligand because similar peaks also appear for the free ligand.</p>
<p>Based on the Fenton-like reaction mechanism, Cu(II) complex NPs can catalyze H<sub>2</sub>O<sub>2</sub> to &#x2022;OH (<xref ref-type="bibr" rid="B18">Liu C et al., 2019</xref>; <xref ref-type="bibr" rid="B2">Bao et al., 2020</xref>). In order to study the catalytic performance of the complex NPs, MB was selected as an indicator of ROS in the presence of H<sub>2</sub>O<sub>2</sub>. As shown in <xref ref-type="fig" rid="F1">Figure 1C</xref>, the absorbance of MB decreased <italic>via</italic> oxidation when the complex NPs were added, indicating the effective generation of &#x2022;OH. In contrast, no obvious absorbance decrease was observed without NPs even after 30&#xa0;min. The Gd(III)&#x2013;Cu(II) complex can also oxidize GSH to GSSG to further enhance the yield of ROS.</p>
<p>Nanocoprecipitation was used to improve the aqueous solution dispersability of the NPs. SEM (scanning electron microscope) and DLS (dynamic light scattering) were used to characterize the size and diameter of the complex NPs. As shown from <xref ref-type="fig" rid="F1">Figure 1D</xref>, it can be seen that the complex can self-assemble NPs with good dispersion, and the average diameter is about 50&#xa0;nm, suggesting the suitability for EPR. In addition, the stability of the complex in PBS (pH &#x3d; 5.5 and 7.4) and DMEM with 10% FBS was also determined. The complex NPs without PEG<sub>-2000</sub> were retained in the aqueous solutions at RT for 1&#xa0;day. The diffraction patterns are similar to the simulated ones (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>, ESI&#x2020;), suggesting the high-phase purity of the bulk products. In addition, no obvious changes were observed after incubation with the NPs in PBS or in DMEM, indicating their good stability. Moreover, the DLS results showed the diameter of the NPs with a slight aggregation in water, PBS, and DMEM (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>, ESI&#x2020;). This may be due to the low solubility of NPs in aqueous solution and absence of PEG<sub>&#x2212;2000</sub> coating.</p>
</sec>
<sec id="s3-2">
<title>3.2 Crystal Structure of [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O</title>
<p>This complex belongs to the monoclinic space group <italic>P2</italic>
<sub>1</sub>/n with a crystallographic ally-independent symmetric unit. From <xref ref-type="fig" rid="F2">Figure 2</xref>, each Gd(III) atom is nine-coordinated by four oxygen atoms (O1, O2, O3A, and O4A) from two carboxylate groups and five oxygen atoms (O5, O6, O7, O8, and O9) from five water molecules, thus forming a deformed and distorted tricapped trigonal prism coordination configuration. The Cu(II) cation is coordinated with four nitrogen atoms (N1, N5, N1B, and N5B) of the tetrazole ring and two carboxyl oxygen atoms (O1 and O1B) from two L<sup>4&#x2212;</sup> ions, forming a deformed octahedron coordination configuration. In addition, four oxygen atoms from two carboxyl groups of L<sup>4&#x2212;</sup> chelated with two Gd(III) ions (<xref ref-type="fig" rid="F3">Figure 3</xref>), and two&#xa0;N atoms from two tetrazole rings and a carboxyl oxygen atom connected with one Cu(II) ion (<xref ref-type="fig" rid="F7">Scheme 1</xref>). By analyzing the bond lengths of the complex, the bond lengths of Gd&#x2013;O are 2.391&#x2013;2.544&#xa0;&#xc5; and that of Cu&#x2013;O are 2.492&#xa0;&#xc5;. The bond lengths between the Cu atom and N atom are in the range of 1.976&#x2013;1.992&#xa0;&#xc5;. As shown in <xref ref-type="fig" rid="F4">Figure 4</xref>, two such ligands set up a double bridge between two Cu(II) ions and two Gd(III) ions to generate a bimetallacycle of [Cu<sub>2</sub>Gd<sub>2</sub>(L)<sub>2</sub>]. The adjacent bimetallacycle is further connected to yield a one-dimensional chain structure, and by hydrogen bonding between the chains, a three-dimensional supramolecular structure was formed (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> Diagram of the coordination environment of the Gd(III) and Cu(II) center in the complex [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O. <bold>(B)</bold> Distorted tricapped trigonal prism of Gd(III).</p>
</caption>
<graphic xlink:href="fchem-10-856495-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Coordination mode diagram of the H<sub>4</sub>L.</p>
</caption>
<graphic xlink:href="fchem-10-856495-g003.tif"/>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>One-dimensional structure of the complex [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O observed along the b-axis direction.</p>
</caption>
<graphic xlink:href="fchem-10-856495-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>3D structure diagram of the complex [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O formed by hydrogen bond interaction.</p>
</caption>
<graphic xlink:href="fchem-10-856495-g005.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Cytotoxicity and Trypan Blue Staining</title>
<p>The MTT assay was performed to further investigate the cytotoxicity of the complex NPs. Different concentrations of NPs of the complex were cultured with HeLa, HepG2, and HT29 cells. As shown in <xref ref-type="fig" rid="F6">Figures 6A&#x2013;C</xref>, the cell viability of the group cultured with H<sub>4</sub>L remained high even at high concentration, which demonstrated the low cytotoxicity of the ligand. The complex NPs displayed promising cytotoxic activity against all the three cancer cell lines. As the NPs concentration increases, the cell viability decreases, and the IC<sub>50</sub> values of HeLa, HepG2, and HT29 cells are calculated to be approximately 4.9&#xa0;&#x3bc;g/ml (0.90&#xa0;&#x3bc;M), 11.1&#xa0;&#x3bc;g/ml (2.05&#xa0;&#x3bc;M), and 5.5&#xa0;&#x3bc;g/ml (1.01&#xa0;&#x3bc;M), respectively. Among them, the IC<sub>50</sub> of the complex for HeLa was the lowest, which is superior to that of the previously reported Cu complexes with tetrazole (triazole)&#x2013;carboxylate as ligands, such as [Cu(2-pytzipa)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub>]&#xb7;2H<sub>2</sub>O (7&#xa0;&#x3bc;M) (<xref ref-type="bibr" rid="B44">Zhai et al., 2017</xref>), [Cu(atzpa)<sub>2</sub>], [Cu(pytzipa)<sub>2</sub>], [Cu<sub>4</sub>(Hphtz)<sub>8</sub>](ClO<sub>4</sub>)<sub>4</sub>&#xb7;4H<sub>2</sub>O (<xref ref-type="bibr" rid="B45">Zhang et al., 2021</xref>), [Cu(L<sup>1</sup>)<sub>2</sub>(ClO<sub>4</sub>)<sub>2</sub>]&#x2219;2MeCN [Cu(L<sup>1</sup>)<sub>2</sub>(MeOH)<sub>2</sub>](ClO<sub>4</sub>)<sub>2</sub>, and [Cu(L<sup>3</sup>)<sub>2</sub>(NO<sub>3</sub>)<sub>2</sub>]&#x2219;3H<sub>2</sub>O (<xref ref-type="bibr" rid="B11">Li et al., 2021</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>), and also superior to various transition metal complexes based on tetrazole&#x2013;carboxylate, such as [Zn (pytzipa)<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>]&#xb7;2H<sub>2</sub>O (35&#xa0;&#x3bc;g/ml) (<xref ref-type="bibr" rid="B5">Gu et al., 2018</xref>), Ca (2-pytzipa)<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>] (48&#xa0;&#x3bc;g/ml), and [Ca(3-pytzipa)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub>]n (30&#xa0;&#x3bc;g/ml) (<xref ref-type="bibr" rid="B3">Cao et al., 2019</xref>). This result also demonstrated that the Cu(II)-containing complex was able to effectively decrease the GSH level in the solution to induce cell apoptosis (<xref ref-type="bibr" rid="B29">Tang et al., 2019</xref>). On the contrary, the overexpression of GSH can reduce the reaction of Cu(II) to Cu(I) <italic>via</italic> Fenton-like reaction, further improving the production rate of &#x2022;OH and reducing the antioxidant capacity of tumor cells (<xref ref-type="bibr" rid="B19">Liu Y et al., 2019</xref>). From the abovementioned fact, the Gd(III)&#x2013;Cu(II) complex showed better apoptosis-inducing effect than most copper compounds; this may be because the addition of Gd(III) increased the uptake of NPs by cancer cells, resulting in a more efficient CDT therapeutic effect (<xref ref-type="bibr" rid="B10">Lee et al., 2015</xref>; <xref ref-type="bibr" rid="B24">Ren et al., 2019</xref>; <xref ref-type="bibr" rid="B42">Zeng et al., 2020</xref>; <xref ref-type="bibr" rid="B26">Stinnett et al., 2021</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>
<bold>(A&#x2013;C)</bold> In vitro MTT assay of HeLa, HepG2, and HT29 cells was treated with ligand H4L and complex NPs; trypan blue fluorescent staining of the control group for <bold>(D)</bold> HeLa cells, <bold>(E)</bold> HepG2 cells, and <bold>(F)</bold> HT29 cells; Complex NPs for <bold>(G)</bold> HeLa cells <bold>(H)</bold> HepG2 cells <bold>(I)</bold> HT29 cells.</p>
</caption>
<graphic xlink:href="fchem-10-856495-g006.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Comparison of cytotoxicity with other Cu(II) complexes for HeLa cells.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Complex</th>
<th align="center">IC<sub>50</sub> (&#x3bc;g/ml)</th>
<th align="center">Reference</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">[Cu(atzpa)<sub>2</sub>]</td>
<td align="char" char=".">41.45</td>
<td align="left">
<xref ref-type="bibr" rid="B45">Zhang et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">[Cu(pytzipa)<sub>2</sub>]</td>
<td align="char" char=".">33.76</td>
<td align="left">
<xref ref-type="bibr" rid="B45">Zhang et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">[Cu<sub>4</sub>(Hphtz)<sub>8</sub>](ClO<sub>4</sub>)<sub>4</sub>&#xb7;4H<sub>2</sub>O</td>
<td align="char" char=".">28.92</td>
<td align="left">
<xref ref-type="bibr" rid="B45">Zhang et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">[Cu(L<sup>1</sup>)<sub>2</sub>(ClO<sub>4</sub>)<sub>2</sub>]&#x2219;2MeCN</td>
<td align="char" char=".">92.3</td>
<td align="left">
<xref ref-type="bibr" rid="B11">Li et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">[Cu(L<sup>1</sup>)<sub>2</sub> (MeOH)<sub>2</sub>](ClO<sub>4</sub>)<sub>2</sub>
</td>
<td align="char" char=".">67.5</td>
<td align="left">
<xref ref-type="bibr" rid="B11">Li et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">[Cu(L<sup>3</sup>)<sub>2</sub>(NO<sub>3</sub>)<sub>2</sub>]&#x2219;3H<sub>2</sub>O</td>
<td align="char" char=".">73.7</td>
<td align="left">
<xref ref-type="bibr" rid="B11">Li et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">[Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O</td>
<td align="char" char=".">4.9</td>
<td align="left">This work</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>After trypan blue staining, the cell nucleus incubated with the NPs showed a stronger blue&#x2013;white color than the control group, indicating that it had a significant apoptosis-inducing effect to HeLa, HepG2, and HT29 cells (<xref ref-type="fig" rid="F6">Figures 6G&#x2013;I</xref>). From the comparison of these cell morphologies, it can be seen that the morphology of live cells in control groups is irregular, while that of dead cells tends to be regular. In addition, the volume of the dead cells had generally shrunk, possibly due to the mechanism of apoptosis rather than necrosis (<xref ref-type="bibr" rid="B3">Cao et al., 2019</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>4 Conclusion</title>
<p>In conclusion, a new nanobooster [Gd<sub>2</sub>Cu(L)<sub>2</sub>(H<sub>2</sub>O)<sub>10</sub>]&#xb7;6H<sub>2</sub>O was designed and synthesized by the solvothermal reaction. It showed a one-dimensional chain structure and was capable of catalyzing H<sub>2</sub>O<sub>2</sub> to form cytotoxic hydroxyl radicals, indicating its excellent cytotoxicity against the HeLa, HepG2, and HT29 cells as confirmed by the MTT assay and trypan blue staining. HeLa cells are the most sensitive to the NPs. The bimetallic complex has potential in chemodynamic therapy against human cervical, liver, and colon carcinoma cells.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data Availability Statement</title>
<p>Publicly available datasets were analyzed in this study. These data can be found here: CCDC 2103482.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>X-YS, writing&#x2014;original draft; T-XS, data curation; A-LZ, software; L-TT, formal analysis; W-CS, investigation; H-JZ, formal analysis; S-LZ, supervision; Y-LG, supervision; LS, supervision.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>We greatly appreciate financial support from the National Natural Science Foundation of China (Grant Nos. 11405014, 21171093, and 21476115), Jiangsu Science and Technology Department of China (BY2015043-02), the Natural Science Fund of Jiangsu Province of P. R. China (Nos. 14KJB150001 and BK20131212), and the start-up grant from CSLG (No. KYZ2014064Z), China Postdoctoral Science Foundation (2013M541610).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2022.856495/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2022.856495/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arom&#xed;</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Barrios</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Roubeau</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gamez</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Triazoles and Tetrazoles: Prime Ligands to Generate Remarkable Coordination Materials</article-title>. <source>Coord. Chem. Rev.</source> <volume>255</volume>, <fpage>485</fpage>&#x2013;<lpage>546</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2010.10.038</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname>
<given-names>Y.-W.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>X.-W.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.-G.</given-names>
</name>
</person-group> (<year>2020</year>). <source>Research</source> <volume>2020</volume>, <fpage>9301215</fpage>. <pub-id pub-id-type="doi">10.34133/2020/9301215</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A Novel Mn-Cu Bimetallic Complex for Enhanced Chemodynamic Therapy with Simultaneous Glutathione Depletion</article-title>. <source>Chem. Commun.</source> <volume>55</volume>, <fpage>12956</fpage>&#x2013;<lpage>12959</lpage>. <pub-id pub-id-type="doi">10.1039/c9cc06040e</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.-F.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M.-F.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>F.-K.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Anion-directed Self-Assembly of Cu(II) Coordination Compounds with Tetrazole-1-Acetic Acid: Syntheses in Ionic Liquids and Crystal Structures</article-title>. <source>New J. Chem.</source> <volume>38</volume>, <fpage>269</fpage>&#x2013;<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1039/c3nj01198d</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Peh</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Substituent-dependent Formation of Co(II) Complexes Based on Phenyl-Tetrazole Acetic Acid: From bis- to Tristetrazole Acetic Acid</article-title>. <source>Acta Chim. Sin.</source> <volume>69</volume>, <fpage>1253</fpage>&#x2013;<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.1007/s11243-016-0099-3</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>X. Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q. Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Isomer Directed Assembly of Two Ca(II) Compounds Based on 5-(n-Pyridyl)tetrazole-2-Isopropanoic Acid (N &#x3d; 2, 3) and Action against Hela Cells</article-title>. <source>J. Coord. Chem.</source> <volume>71</volume>, <fpage>3589</fpage>&#x2013;<lpage>3599</lpage>. <pub-id pub-id-type="doi">10.1080/00958972.2018.1522433</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G. W.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Regulation of Deprotonation of 3,3-di(1H-Tetrazol-5-Yl)pentanedioic Acid: Solvothermal Synthesis of La(III) and Heterometallic La(III)/Cu(II) Compounds for Ablation of A549 Cells</article-title>. <source>J. Solid State. Chem.</source> <volume>259</volume>, <fpage>104</fpage>&#x2013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.jssc.2018.01.006</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S. Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>A Glucose/Oxygen&#x2010;Exhausting Nanoreactor for Starvation&#x2010; and Hypoxia&#x2010;Activated Sustainable and Cascade Chemo&#x2010;Chemodynamic Therapy</article-title>. <source>Small</source> <volume>16</volume> (<issue>31</issue>), <fpage>2000897</fpage>. <pub-id pub-id-type="doi">10.1002/smll.202000897</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H.-S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.-M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.-T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.-L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.-T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Synthesis, Structure, thermal Behavior and Energetic Properties of a New 2D Polymeric Ba(II) Compound with Tetrazole-1-Acetic Acid</article-title>. <source>Main. Group Chem.</source> <volume>12</volume>, <fpage>197</fpage>&#x2013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.3233/mgc-130097</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F. G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Chemodynamic Therapy via Fenton and Fenton&#x2010;Like Nanomaterials: Strategies and Recent Advances</article-title>. <source>Small</source> <volume>18</volume> (<issue>6</issue>), <fpage>2103868</fpage>. <pub-id pub-id-type="doi">10.1002/smll.202103868</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Hyeon</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cheon</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy</article-title>. <source>Chem. Rev.</source> <volume>115</volume>, <fpage>10637</fpage>&#x2013;<lpage>10689</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.5b00112</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Synthesis of Three New Copper(II) Compounds for Chemodynamic Therapy against Cancer Cells</article-title>. <source>Inorg. Chim. Acta</source> <volume>520</volume>, <fpage>120295</fpage>. <pub-id pub-id-type="doi">10.1016/j.ica.2021.120295</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>B. Z.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>One-Step Formulation of Targeted Aggregation-Induced Emission Dots for Image-Guided Photodynamic Therapy of Cholangiocarcinoma</article-title>. <source>ACS Nano</source> <volume>11</volume>, <fpage>3922</fpage>&#x2013;<lpage>3932</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.7b00312</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q. Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>L. J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Substituted group directed assembly of zinc coordination compounds based on bifunctional ligands, from mono, di to tristetrazole-carboxylate</article-title>. <source>RSC Adv.</source> <volume>5</volume>, <fpage>43741</fpage>&#x2013;<lpage>43749</lpage>. <pub-id pub-id-type="doi">10.1039/c5ra03848k</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.-M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.-L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.-T.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.-N.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.-G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Synthesis, Structure, and thermal Behavior of a 2-D Polymeric Ca(II) Compound with Tetrazole-1-Acetic Acid</article-title>. <source>J. Coord. Chem.</source> <volume>66</volume>, <fpage>1276</fpage>&#x2013;<lpage>1286</lpage>. <pub-id pub-id-type="doi">10.1080/00958972.2013.782007</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Guanand</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Syntheses, structures and properties of seven isomorphous 1D Ln<sup>3&#x002B;</sup> complexes Ln(BTA)(HCOO)(H<sub>2</sub>O)<sub>3</sub> (H<sub>2</sub>BTA &#x003D; bis(tetrazoly)amine, Ln &#x003D; Pr, Gd, Eu, Tb, Dy, Er, Yb) and two 3D Ln<sup>3&#x002B;</sup> complexes Ln(HCOO)<sub>3</sub> (Ln &#x003D; Pr, Nd)</article-title>. <source>Dalton. Trans.</source>, <fpage>6165</fpage>&#x2013;<lpage>6169</lpage>. <pub-id pub-id-type="doi">10.1039/B808394K</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>L.-S.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO<sub>2</sub> -Based Nanoagent to Enhance Chemodynamic Therapy</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>57</volume> (<issue>18</issue>), <fpage>4902</fpage>&#x2013;<lpage>4906</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201712027</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Biodegradable Biomimic Copper/Manganese Silicate Nanospheres for Chemodynamic/Photodynamic Synergistic Therapy with Simultaneous Glutathione Depletion and Hypoxia Relief</article-title>. <source>ACS Nano</source> <volume>13</volume> (<issue>4</issue>), <fpage>4267</fpage>&#x2013;<lpage>4277</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.8b09387</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Copper(I) Phosphide Nanocrystals for <italic>In Situ</italic> Self&#x2010;Generation Magnetic Resonance Imaging&#x2010;Guided Photothermal&#x2010;Enhanced Chemodynamic Synergetic Therapy Resisting Deep&#x2010;Seated Tumor</article-title>. <source>Adv. Funct. Mater.</source> <volume>29</volume>, <fpage>1904678</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.201904678</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>D.-S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.-T.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.-G.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.-D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Syntheses, Structures and Investigation of the Properties of Mercury Coordination Polymers Based on 5-Amino-Tetrazolate Ligands</article-title>. <source>CrystEngComm</source> <volume>18</volume>, <fpage>7865</fpage>&#x2013;<lpage>7872</lpage>. <pub-id pub-id-type="doi">10.1039/c6ce01790h</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>D.-S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.-T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.-P.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S.-J.</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Synthesis, Structures, and Properties of Three Zn(II), Mn(II), and Cd(II) Compounds Based on Tetrazole-1-Acetic Ligand</article-title>. <source>J. Solid State. Chem.</source> <volume>226</volume>, <fpage>186</fpage>&#x2013;<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/j.jssc.2015.02.024</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W. T.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C. C.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Two New Zn(II) and Cd(II) Coordinastion Polymers Based on Amino-Tetrazole and Phenylcarboxylate: Syntheses, Topological Structures and Photoluminescent Properties</article-title>. <source>J. Solid Statechem.</source> <volume>196</volume>, <fpage>161</fpage>&#x2013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/j.jssc.2012.06.011</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palao</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Slanina</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Muchov&#xe1;</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>&#x160;olomek</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>V&#xed;tek</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kl&#xe1;n</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Transition-Metal-Free CO-Releasing BODIPY Derivatives Activatable by Visible to NIR Light as Promising Bioactive Molecules</article-title>. <source>J. Am. Chem. Soc.</source> <volume>138</volume>, <fpage>126</fpage>&#x2013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b10800</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A Metal-Polyphenol&#x2010;Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy</article-title>. <source>Adv. Mater.</source> <volume>32</volume>, <fpage>1906024</fpage>. <pub-id pub-id-type="doi">10.1002/adma.201906024</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheldrick</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>A Short History ofSHELX</article-title>. <source>Acta Cryst. Sect A.</source> <volume>64</volume>, <fpage>112</fpage>&#x2013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1107/s0108767307043930</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stinnett</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Taheri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Villanova</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bohloul</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>E. P.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>2D Gadolinium Oxide Nanoplates as T 1 Magnetic Resonance Imaging Contrast Agents</article-title>. <source>Adv. Healthc. Mater.</source> <volume>10</volume>, <fpage>2001780</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.202001780</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G. W.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <source>Transit. Met. Chem.</source> <volume>41</volume>, <fpage>943</fpage>&#x2013;<lpage>949</lpage>.</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J.-B.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Novel Tetrazole-Based Metal-Organic Frameworks Constructed from <italic>In Situ</italic> Synthesize Bifunctional Ligands: Syntheses, Structure and Luminescent Properties</article-title>. <source>CrystEngComm</source> <volume>14</volume>, <fpage>890</fpage>&#x2013;<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1039/c1ce05829k</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Chemodynamic Therapy: Tumour Microenvironment&#x2010;Mediated Fenton and Fenton&#x2010;like Reactions</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>58</volume>, <fpage>946</fpage>&#x2013;<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201805664</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wriedt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sculley</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Yakovenko</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Halder</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Balbuena</surname>
<given-names>P. B.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Low-Energy Selective Capture of Carbon Dioxide by a Pre-designed Elastic Single-Molecule Trap</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>51</volume>, <fpage>9804</fpage>&#x2013;<lpage>9808</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201202992</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wriedt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yakovenko</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Halder</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Prosvirin</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Dunbar</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.-C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Reversible Switching from Antiferro- to Ferromagnetic Behavior by Solvent-Mediated, Thermally-Induced Phase Transitions in a Trimorphic MOF-Based Magnetic Sponge System</article-title>. <source>J. Am. Chem. Soc.</source> <volume>135</volume>, <fpage>4040</fpage>&#x2013;<lpage>4050</lpage>. <pub-id pub-id-type="doi">10.1021/ja312347p</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>M.-F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.-F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>F.-K.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Structures and Photoluminescence of Zinc(ii) Coordination Polymers Based on <italic>In Situ</italic> Generated 1H-Tetrazolate-5-Propionic Acid Ligands</article-title>. <source>CrystEngComm</source> <volume>13</volume>, <fpage>6386</fpage>. <pub-id pub-id-type="doi">10.1039/c1ce05281k</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>pH Dependent Synthesis of Structurally Diverse Praseodymium(III) Coordination Polymers Based on Isomeric Ligands</article-title>. <source>Inorg. Chem. Commun.</source> <volume>62</volume>, <fpage>111</fpage>&#x2013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.inoche.2015.10.035</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Two Ru(II) Compounds with Aggregation Induced Emission as Promising Photosensitizers for Photodynamic Therapy</article-title>. <source>J. Inorg. Biochem.</source> <volume>212</volume>, <fpage>111233</fpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2020.111233</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F. F.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Substituted Group Directed Assembly of Energetic lead(ii) Compounds Based on Structure-Relevant Ligands</article-title>. <source>RSC Adv.</source> <volume>5</volume>, <fpage>84439</fpage>&#x2013;<lpage>84445</lpage>. <pub-id pub-id-type="doi">10.1039/c5ra17301a</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Photochemical Property of a Ru(ii) Compound Based on 3-(2-pyridyl)pyrazole and 2,2&#x2032;-bipyridine for Ablation of Cancer Cells</article-title>. <source>New J. Chem.</source> <volume>42</volume>, <fpage>5395</fpage>&#x2013;<lpage>5402</lpage>. <pub-id pub-id-type="doi">10.1039/c7nj05034h</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>(2-(4-Bromophenyl)ethene-1,1,2-triyl)tribenzene with Aggregation Induced Emission for Ablation of HeLa Cells</article-title>. <source>Mater. Chem. Front.</source> <volume>2</volume>, <fpage>1842</fpage>&#x2013;<lpage>1846</lpage>. <pub-id pub-id-type="doi">10.1039/c8qm00304a</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Two Photoactive Ru (II) Compounds Based on Tetrazole Ligands for Photodynamic Therapy</article-title>. <source>J. Inorg. Biochem.</source> <volume>210</volume>, <fpage>111127</fpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2020.111127</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>Y.-T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.-T. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Syntheses, Structures and Properties of Five Coordinating Metallic Complexes with the New Carboxylate-Bis(tetrazolyl)amine Ligand</article-title>. <source>Inorg. Chim. Acta</source> <volume>419</volume>, <fpage>73</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.ica.2014.04.013</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Photochemical Property of Two Ru(II) Compounds Based on 5-(2-pyrazinyl)tetrazole for Cancer Phototherapy by Changing Auxiliary Ligand</article-title>. <source>J. Inorg. Biochem.</source> <volume>193</volume>, <fpage>124</fpage>&#x2013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2019.01.015</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>F. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X. Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Supramolecular Coordination Complexes as Diagnostic and Therapeutic Agents</article-title>. <source>Curr. Opin. Chem. Biol.</source> <volume>61</volume>, <fpage>19</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2020.08.007</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Engineered Gadolinium-Based Nanomaterials as Cancer Imaging Agents</article-title>. <source>Appl. Mater. Today</source> <volume>20</volume>, <fpage>100686</fpage>. <pub-id pub-id-type="doi">10.1016/j.apmt.2020.100686</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z. K.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y. J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>pH Dependent Synthesis of Two Zinc(II) Compounds Derived from 5-Aminotetrazole-1-Isopropanoic Acid for Treatment of Cancer Cells</article-title>. <source>J. Solid State. Chem.</source> <volume>258</volume>, <fpage>156</fpage>&#x2013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/j.jssc.2017.10.013</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>One Cu(II) Compound Derived from 5-(2-Pyridyl)tetrazole-2-Isopropanoic Acid against Hela Cells</article-title>. <source>Inorg. Chem. Commun.</source> <volume>84</volume>, <fpage>150</fpage>&#x2013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.inoche.2017.08.018</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>A.-L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.-C.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L.-T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.-L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.-G.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Synthesis and Anticancer Property of Three New Cu(II) Coordination Polymers Constructed by the Bifunctional Substituted-Polynitrogen Heterocyclic Ligands</article-title>. <source>Inorg. Chim. Acta</source> <volume>522</volume>, <fpage>120380</fpage>. <pub-id pub-id-type="doi">10.1016/j.ica.2021.120380</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>Q. Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>L. J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Two Energetic Cobalt(II) Coordination Polymers Derived from Isomeric Ligands</article-title>. <source>J. Inorg. Organomet. Polym.</source> <volume>26</volume>, <fpage>616</fpage>&#x2013;<lpage>622</lpage>. <pub-id pub-id-type="doi">10.1007/s10904-016-0343-5</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T. Y.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>W. T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Synthesis and Anticancer Property of Zn(II) Compounds Nanoparticles Based on Tetrazole Carboxylate Ligands</article-title>. <source>Inorg. Chim. Acta</source> <volume>487</volume>, <fpage>70</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.ica.2018.12.005</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D.-Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.-W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.-Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Synthesis, crystal Structure and Catalytic Property of a New Samarium Compound Derived from 5-(pyrazin-2-Yl)tetrazole-2-Acetic Acid</article-title>. <source>RSC Adv.</source> <volume>5</volume>, <fpage>27887</fpage>&#x2013;<lpage>27890</lpage>. <pub-id pub-id-type="doi">10.1039/c5ra03296b</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>D.-L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.-F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.-S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.-Y.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Three New Coordination Compounds with Neodymium Based on Tetrazole Containing Carboxylic Acid Ligands</article-title>. <source>Z. Anorg. Allg. Chem.</source> <volume>640</volume>, <fpage>2226</fpage>&#x2013;<lpage>2231</lpage>. <pub-id pub-id-type="doi">10.1002/zaac.201400106</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>